{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:17:14Z","timestamp":1769059034675,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00895","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T10:27:49Z","timestamp":1556274469000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia"],"prefix":"10.3389","volume":"10","author":[{"given":"Menno C.","family":"van Zelm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsus","family":"Pumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Shuttleworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei M.","family":"Aui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne M.","family":"Smart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian J.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics."},{"key":"B2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature."},{"key":"B4","first-page":"595","article-title":"Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection","volume":"91","author":"Futatani","year":"1998","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10875-015-0132-x","article-title":"Are patients with X-linked agammaglobulinemia at increased risk of developing acute lymphoblastic leukemia?","volume":"35","author":"Conley","year":"2015","journal-title":"J Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-Linked Agammaglobulinaemia: outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/cei.13068","article-title":"Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy","volume":"191","author":"Stubbs","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1521-6616(03)00045-7","article-title":"Stem cell transplants for patients with X-linked agammaglobulinemia","volume":"107","author":"Howard","year":"2003","journal-title":"Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/pbc.25554","article-title":"Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia","volume":"62","author":"Abu-Arja","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13045-016-0240-y","article-title":"Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity","volume":"9","author":"Ikegame","year":"2016","journal-title":"J Hematol Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia."},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1203\/00006450-200202000-00007","article-title":"Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children","volume":"51","author":"Noordzij","year":"2002","journal-title":"Pediatr Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/bjh.13073","article-title":"Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): technical recommendations for the use of short tandem repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group","volume":"168","author":"Clark","year":"2015","journal-title":"Br J Haematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.bbmt.2014.07.003","article-title":"Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"20","author":"Reshef","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.3324\/haematol.2012.076786","article-title":"TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy","volume":"98","author":"Chiaretti","year":"2013","journal-title":"Haematologica."},{"key":"B18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"B19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","article-title":"Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?","volume":"21","author":"Boissel","year":"2003","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10875-015-0127-7","article-title":"X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia","volume":"35","author":"Hoshino","year":"2015","journal-title":"J Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20030615","article-title":"Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells","volume":"198","author":"Kersseboom","year":"2003","journal-title":"J Exp Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bjc.2017.152","article-title":"Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia","volume":"117","author":"Forero-Castro","year":"2017","journal-title":"Br J Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood-2009-05-222166","article-title":"Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway","volume":"115","author":"Ta","year":"2010","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1189\/jlb.0705402","article-title":"p53 regulates Btk-dependent B cell proliferation but not differentiation","volume":"79","author":"Schmidt","year":"2006","journal-title":"J Leukoc Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/1744666X.2018.1424627","article-title":"Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications","volume":"14","author":"Slatter","year":"2018","journal-title":"Expert Rev Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.bbmt.2018.04.023","article-title":"Allogeneic hematopoietic stem cell transplantation to cure transfusion-dependent thalassemia: timing matters!","volume":"24","author":"Peters","year":"2018","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T23:20:41Z","timestamp":1663370441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2019.00895"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00895","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"article-number":"895"}}